Pricing Log in Create free account

Candel Therapeutics, Inc. (CADL) vs Sana Biotechnology, Inc. (SANA)

Candel Therapeutics, Inc. and Sana Biotechnology, Inc. are both Biotechnology companies. Candel Therapeutics, Inc. and Sana Biotechnology, Inc. are of similar size ($705.5M and $686.2M). Across the 10 metrics below, Candel Therapeutics, Inc. leads on 5 and Sana Biotechnology, Inc. on 5.

Valuation

Metric CADL SANA Biotechnology median
P/E n/m n/m 11.58
P/S 5,473.85 n/m 9.61
P/B 5.42 3.91 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m n/m 0.72
EV/Sales 4,277.78 n/m 9.43
Earnings yield (15.28%) (23.04%) (32.28%)
Free cash flow yield (8.37%) (20.42%) (22.27%)

Profitability

Metric CADL SANA Biotechnology median
Gross margin 0.00% 0.00% 68.81%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (81.84%) (79.47%) (50.30%)
Return on assets (56.37%) (36.79%) (45.47%)
Return on invested capital 0.00% (178.50%) 0.00%

Growth

Metric CADL SANA Biotechnology median
Revenue growth (TTM) 0.00% — 6.78%
EPS growth (last fiscal year) 58.62% 17.24% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CADL SANA Biotechnology median
Debt to equity 0.38 0.00 0.00
Current ratio 16.09 1.77 4.74
Net debt to EBITDA 1.53 0.60 1.01

Dividend

Metric CADL SANA Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric CADL SANA Biotechnology median
Market cap 705.50m 686.16m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack